7th Cell Therapy Analytical Development Summit
With cell therapy programs advancing into later clinical stages and regulatory scrutiny tightening, early analytical strategy has never been more important.
It is in the shadow of these changes that the 7th Cell Therapy Analytical Development Summit returns to unite the field.
From designing assays that can withstand validation, streamlining tech transfers, and decoding mechanisms of action from day one, to building robust, predictive, and compliant analytical frameworks, this year’s program will prepare you for the next wave of analytical hurdles.
Be among the first to view the brand-new program!
We will take your expertise further with:
- A hands-on workshop with SuperNova FlowCytometry to design GMP- and IVD-ready assays – earn three CMLE credits!
- The latest insights on US Pharmacopoeia’s new microbial testing chapters and rapid test validation from National Institute of Health, BioNTech, Vertex, and the University of Calgary.
- Exclusive assay and tech transfer case studies from Quell Therapeutics and Dana Farber Cancer Institute to streamline validation and reduce variability.
- Novel tools and technologies to enhance your predictive modeling and MoA understanding with Avobis Bio, Genentech, and Cellectis.
Join us in fast-tracking the next era of safe, potent, and robust cell therapies to market!
Quick Links: 2025 Program | Registration
